Skip to content

Read-only version: For security reasons, the Research Information System (FIS) has been temporarily replaced by this read-only version. All public content and full texts remain available; login, editing, submission and statistics are not available. Questions: fis@uni-bamberg.de

Home › Publications › Effect of automated insulin delivery systems on person-reported outcomes in people with diabetes : a systematic review and meta-analysis

Publication

Effect of automated insulin delivery systems on person-reported outcomes in people with diabetes : a systematic review and meta-analysis

Roos, Timm; Hermanns, Norbert; Groß, Christopher; u. a. (2024): Effect of automated insulin delivery systems on person-reported outcomes in people with diabetes : a systematic review and meta-analysis, in: eClinicalMedicine, Amsterdam: Elsevier BV, Jg. 76, Nr. 102852, S. 1–18, doi: 10.1016/j.eclinm.2024.102852.

Details

Faculty/Chair
Faculty/Professorship
Author
Groß, Christopher
Haak, Thomas
Title of the Journal
eClinicalMedicine
ISSN
2589-5370
Publisher Information
Elsevier BV : Amsterdam
Year of publication
2024
Volume
76
Issue
102852
Language
English
DOI
Abstract

Background:

Conclusive evidence on the benefits of automated insulin delivery (AID) systems on person-reported outcomes (PROs) is missing.

Methods:

In this systematic review and meta-analysis, four databases (PubMed, PsycINFO, Cochrane, and GoogleScholar) were searched from inception up to August 7th, 2024. All types of studies were included if studies reported on PROs in people with diabetes using an AID system. All types of control groups in randomised controlled trials (RCT) were included. Summary data were extracted by three reviewers. Main outcomes focused on diabetes distress, fear of hypoglycaemia and quality of life. Meta-analyses were conducted for RCTs and observational studies separately. When five or more studies could be pooled, random-effects meta-analysis was used, otherwise common-effects meta-analysis was used. Risk of bias was evaluated with Cochrane tools. This study was registered with PROSPERO, CRD42022352502.

Findings:

A total of 62 studies (n = 9253) were included reporting on 45 different questionnaires. Twenty-seven studies were RCTs and 25 were observational studies. RCT meta-analyses showed reduced diabetes distress (standardised mean difference [95% CI]: −0.159 [−0.309, −0.010], I2 = 23.0%), reduced fear of hypoglycaemia (−0.339 [−0.566, −0.111], I2 = 42.6%), and improved hypoglycaemia unawareness (−0.231 [−0.424, −0.037], I2 = 0.0%), quality of life in adults (0.347 [0.134, 0.560], I2 = 0.0%) and children/adolescents (0.249 [0.050, 0.448], I2 = 0.0%). Observational meta-analyses corroborated improvements in diabetes distress (−0.217 [−0.403, −0.031], I2 = 68.5%), fear of hypoglycaemia (−0.445 [−0.540, −0.349], I2 = 0.0%), hypoglycaemia unawareness (−0.212 [−0.419, −0.004], I2 = 0.0%), and showed improved sleep quality (−0.158 [−0.255, −0.061], I2 = 0.0%).

Interpretation:

We found low to moderate effect sizes indicating that AID therapy is associated with reduced burden and improved well-being in people with diabetes. Evidence comes from both RCTs and observational studies. However, for some PROs only a limited number of studies could be pooled with a large heterogeneity in questionnaires used. More research is needed with a more uniformed assessment of PROs to demonstrate the added value of AID therapy on psychosocial outcomes.

Keywords
Diabetes mellitus
Automated insulin delivery
Person-reported outcomes
Meta-analysis
Systematic review
DDC Classification
610 Medicine & health
RVK Classification
YC 6400
Peer Reviewed
yes
International Distribution
yes
Open Access Journal
yes
Type
Article
URI
Activation date
2024-11-20

Permalink: https://fis.uni-bamberg.de/handle/uniba/104715 · Data as JSON · Cite: BibTeX · RIS

Data as of: 2026-11-16

Restricted read-only access: login, editing and submission are temporarily disabled.